These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. DMPA for contraception discussed by international forum of experts. Netw Int Fertil Res Program; 1979 Oct; ():2-3. PubMed ID: 12261372 [TBL] [Abstract][Full Text] [Related]
24. Injectable hormones and regulatory controversy: an end to the long-running story? Klitsch M Fam Plann Perspect; 1993; 25(1):37-40. PubMed ID: 8432375 [TBL] [Abstract][Full Text] [Related]
25. What is breast cancer risk with Depo-Provera? Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459 [TBL] [Abstract][Full Text] [Related]
26. Adolescent knowledge and use of injectable contraceptives in developing countries. Singh S J Adolesc Health; 1995 May; 16(5):396-404. PubMed ID: 7662691 [TBL] [Abstract][Full Text] [Related]
27. Depo-Provera: an injectable contraceptive. Wigington S Nurs Times; 1981 Oct 14-20; 77(42):1794-8. PubMed ID: 6458020 [TBL] [Abstract][Full Text] [Related]
28. Injectable contraception: the USA perspective. Kaunitz AM IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920 [TBL] [Abstract][Full Text] [Related]
29. Depo-Provera: new developments in a decade-old controversy. Gold RB; Willson PD Fam Plann Perspect; 1981; 13(1):35-9. PubMed ID: 6452287 [TBL] [Abstract][Full Text] [Related]
30. DES exposure and the aging woman: mothers and daughters. Laitman CJ Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312 [TBL] [Abstract][Full Text] [Related]
32. Cyclofem shoots into injectable market. Family Plan World; 1992; ():19. PubMed ID: 12290896 [TBL] [Abstract][Full Text] [Related]
33. USAID negotiating Depo purchase, but shelf life proves problematic. Family Plan World; 1993; 3(4):7, 21. PubMed ID: 12288090 [TBL] [Abstract][Full Text] [Related]
34. Prenatal diethylstilbestrol exposure and risk of breast cancer. Palmer JR; Wise LA; Hatch EE; Troisi R; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Herbst AL; Noller KL; Hyer M; Hoover RN Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1509-14. PubMed ID: 16896041 [TBL] [Abstract][Full Text] [Related]
35. Millions of couples to have choice of injectable contraceptive. Integration; 1996; (47):41. PubMed ID: 12347310 [TBL] [Abstract][Full Text] [Related]
36. New year, new option: Cyclo-Provera awaits word. Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212 [TBL] [Abstract][Full Text] [Related]
37. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. Harel Z; Biro FM; Kollar LM J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688 [TBL] [Abstract][Full Text] [Related]
38. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland. Snedeker SM; Diaugustine RP Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798 [TBL] [Abstract][Full Text] [Related]
40. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. van Leeuwen FE Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]